Integral Health Asset Management LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 300,000 shares of the company's stock, valued at approximately $11,895,000. Integral Health Asset Management LLC owned 0.32% of Acadia Healthcare as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in ACHC. Treasurer of the State of North Carolina increased its position in Acadia Healthcare by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock worth $1,586,000 after purchasing an additional 250 shares in the last quarter. Nisa Investment Advisors LLC increased its position in Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after purchasing an additional 301 shares in the last quarter. Coldstream Capital Management Inc. increased its position in Acadia Healthcare by 4.9% during the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after purchasing an additional 303 shares in the last quarter. Covestor Ltd grew its holdings in Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares during the period. Finally, Pacer Advisors Inc. increased its stake in shares of Acadia Healthcare by 2.4% during the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock valued at $549,000 after acquiring an additional 325 shares during the last quarter.
Analyst Ratings Changes
ACHC has been the subject of a number of research analyst reports. Mizuho dropped their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research note on Wednesday. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Guggenheim began coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 target price for the company. KeyCorp dropped their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday. Finally, Barclays decreased their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a report on Wednesday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $47.94.
Check Out Our Latest Report on ACHC
Acadia Healthcare Stock Up 1.8%
Shares of Acadia Healthcare stock traded up $0.45 on Friday, hitting $26.09. 1,204,869 shares of the company's stock traded hands, compared to its average volume of 1,697,463. The stock has a market cap of $2.40 billion, a P/E ratio of 8.55, a PEG ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm's 50-day moving average is $26.25 and its 200 day moving average is $35.83. Acadia Healthcare Company, Inc. has a 52-week low of $20.36 and a 52-week high of $82.41.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business's revenue was up .3% on a year-over-year basis. During the same period in the prior year, the business posted $0.84 EPS. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
